Parallax Volatility Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,000
Closed -$450K 3192
2022
Q4
$450K Hold
10,000
﹤0.01% 1912
2022
Q3
$479K Buy
+10,000
New +$548K ﹤0.01% 1991
2022
Q1
Sell
-2,400
Closed -$361K 3185
2021
Q4
$361K Sell
2,400
-26,700
-92% -$3.6M ﹤0.01% 1530
2021
Q3
$3.47M Buy
+29,100
New +$3.21M ﹤0.01% 960
2021
Q2
Sell
-200
Closed -$18K 1718
2021
Q1
$18K Sell
200
-49,400
-100% -$4.59M ﹤0.01% 1217
2020
Q4
$4.74M Sell
49,600
-154,400
-76% -$15.9M ﹤0.01% 971
2020
Q3
$23.2M Buy
204,000
+158,300
+346% +$16.6M 0.02% 676
2020
Q2
$4.53M Buy
45,700
+23,100
+102% +$1.84M 0.01% 1115
2020
Q1
$1.45M Buy
22,600
+5,300
+31% +$371K ﹤0.01% 1350
2019
Q4
$1.03M Sell
17,300
-115,400
-87% -$7.12M ﹤0.01% 1512
2019
Q3
$7.82M Buy
132,700
+84,300
+174% +$5.38M 0.01% 669
2019
Q2
$3.12M Buy
48,400
+14,800
+44% +$955K ﹤0.01% 896
2019
Q1
$2.13M Buy
+33,600
New +$1.76M ﹤0.01% 976

Other funds holding TNDM

Parallax Volatility Advisers's TNDM Position: Q2 2021 in Review

Parallax Volatility Advisers sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 232 shares — an estimated $20K sold.

Parallax Volatility Advisers first reported a position in TNDM in Q3 2018 and held it in 10 quarters. The position peaked at $3.83M in Q3 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Parallax Volatility Advisers reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 232 Tandem Diabetes Care shares in Q2 2021, an estimated $20K.
  • Parallax Volatility Advisers first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 10 quarters.
  • Parallax Volatility Advisers's Tandem Diabetes Care position peaked at $3.83M in Q3 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.